Literature DB >> 23439477

Fructokinase, Fructans, Intestinal Permeability, and Metabolic Syndrome: An Equine Connection?

Richard J Johnson1, Chris Rivard, Miguel A Lanaspa, Silvia Otabachian-Smith, Takuji Ishimoto, Christina Cicerchi, Peter R Cheeke, Bridgett Macintosh, Tanja Hess.   

Abstract

Fructose is a simple sugar present in honey and fruit, but can also exist as a polymer (fructans) in pasture grasses. Mammals are unable to metabolize fructans, but certain gram positive bacteria contain fructanases and can convert fructans to fructose in the gut. Recent studies suggest that fructose generated from bacteria, or directly obtained from the diet, can induce both increased intestinal permeability and features of metabolic syndrome, especially the development of insulin resistance. The development of insulin resistance is driven in part by the metabolism of fructose by fructokinase C in the liver, which results in oxidative stress in the hepatocyte. Similarly, the metabolism of fructose in the small bowel by intestinal fructokinase may lead to increased intestinal permeability and endotoxemia. While speculative, these observations raise the possibility that the mechanism by which fructans induce laminitis could involve intestinal and hepatic fructokinase. Further studies are indicated to determine the role of fructanases, fructose and fructokinase in equine metabolic syndrome and laminitis.

Entities:  

Keywords:  Equine Metabolic Syndrome; Fructans; Fructokinase; Fructose; Laminitis

Year:  2013        PMID: 23439477      PMCID: PMC3576823          DOI: 10.1016/j.jevs.2012.05.004

Source DB:  PubMed          Journal:  J Equine Vet Sci        ISSN: 0737-0806            Impact factor:   1.583


  58 in total

1.  In vitro digestibility and fermentability of levan and its hypocholesterolemic effects in rats.

Authors:  Y Yamamoto; Y Takahashi; M Kawano; M Iizuka; T Matsumoto; S Saeki; H Yamaguchi
Journal:  J Nutr Biochem       Date:  1999-01       Impact factor: 6.048

2.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

Review 3.  Metabolic effects of fructose and the worldwide increase in obesity.

Authors:  Luc Tappy; Kim-Anne Lê
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

4.  Microbial ecology of the equine hindgut during oligofructose-induced laminitis.

Authors:  Gabriel J Milinovich; Paul C Burrell; Christopher C Pollitt; Athol V Klieve; Linda L Blackall; Diane Ouwerkerk; Erika Woodland; Darren J Trott
Journal:  ISME J       Date:  2008-06-26       Impact factor: 10.302

5.  Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults.

Authors:  Jill A Parnell; Raylene A Reimer
Journal:  Am J Clin Nutr       Date:  2009-04-22       Impact factor: 7.045

6.  Thiazide diuretics exacerbate fructose-induced metabolic syndrome.

Authors:  Sirirat Reungjui; Carlos A Roncal; Wei Mu; Titte R Srinivas; Dhavee Sirivongs; Richard J Johnson; Takahiko Nakagawa
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

7.  Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome.

Authors:  Peter J Turnbaugh; Fredrik Bäckhed; Lucinda Fulton; Jeffrey I Gordon
Journal:  Cell Host Microbe       Date:  2008-04-17       Impact factor: 21.023

8.  Liver adenine nucleotides: fructose-induced depletion and its effect on protein synthesis.

Authors:  P H Mäenpää; K O Raivio; M P Kekomäki
Journal:  Science       Date:  1968-09-20       Impact factor: 47.728

9.  An unusual cause for ketoacidosis.

Authors:  M R Davids; A S Segal; H Brunengraber; M L Halperin
Journal:  QJM       Date:  2004-06

Review 10.  Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?

Authors:  Richard J Johnson; Santos E Perez-Pozo; Yuri Y Sautin; Jacek Manitius; Laura Gabriela Sanchez-Lozada; Daniel I Feig; Mohamed Shafiu; Mark Segal; Richard J Glassock; Michiko Shimada; Carlos Roncal; Takahiko Nakagawa
Journal:  Endocr Rev       Date:  2009-01-16       Impact factor: 19.871

View more
  16 in total

Review 1.  Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.

Authors:  Thomas Jensen; Manal F Abdelmalek; Shelby Sullivan; Kristen J Nadeau; Melanie Green; Carlos Roncal; Takahiko Nakagawa; Masanari Kuwabara; Yuka Sato; Duk-Hee Kang; Dean R Tolan; Laura G Sanchez-Lozada; Hugo R Rosen; Miguel A Lanaspa; Anna Mae Diehl; Richard J Johnson
Journal:  J Hepatol       Date:  2018-02-02       Impact factor: 25.083

Review 2.  Effects of dietary components on intestinal permeability in health and disease.

Authors:  Katayoun Khoshbin; Michael Camilleri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-09-09       Impact factor: 4.052

3.  Ketohexokinase C blockade ameliorates fructose-induced metabolic dysfunction in fructose-sensitive mice.

Authors:  Miguel A Lanaspa; Ana Andres-Hernando; David J Orlicky; Christina Cicerchi; Cholsoon Jang; Nanxing Li; Tamara Milagres; Masanari Kuwabara; Michael F Wempe; Joshua D Rabinowitz; Richard J Johnson; Dean R Tolan
Journal:  J Clin Invest       Date:  2018-04-23       Impact factor: 14.808

Review 4.  "Sweet death": Fructose as a metabolic toxin that targets the gut-liver axis.

Authors:  Mark A Febbraio; Michael Karin
Journal:  Cell Metab       Date:  2021-10-06       Impact factor: 27.287

Review 5.  Hyperosmolarity drives hypertension and CKD--water and salt revisited.

Authors:  Richard J Johnson; Bernardo Rodriguez-Iturbe; Carlos Roncal-Jimenez; Miguel A Lanaspa; Takuji Ishimoto; Takahiko Nakagawa; Ricardo Correa-Rotter; Catharina Wesseling; Lise Bankir; Laura G Sanchez-Lozada
Journal:  Nat Rev Nephrol       Date:  2014-05-06       Impact factor: 28.314

Review 6.  Multilayered Interplay Between Fructose and Salt in Development of Hypertension.

Authors:  Ozgur C Eren; Alberto Ortiz; Baris Afsar; Adrian Covic; Masanari Kuwabara; Miguel A Lanaspa; Richard J Johnson; Mehmet Kanbay
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

Review 7.  Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions.

Authors:  Tomas Hrncir; Lucia Hrncirova; Miloslav Kverka; Robert Hromadka; Vladimira Machova; Eva Trckova; Klara Kostovcikova; Pavlina Kralickova; Jan Krejsek; Helena Tlaskalova-Hogenova
Journal:  Microorganisms       Date:  2021-04-29

Review 8.  The Intestinal Microbiota in Metabolic Disease.

Authors:  Anni Woting; Michael Blaut
Journal:  Nutrients       Date:  2016-04-06       Impact factor: 5.717

9.  Rescue of Fructose-Induced Metabolic Syndrome by Antibiotics or Faecal Transplantation in a Rat Model of Obesity.

Authors:  Blanda Di Luccia; Raffaella Crescenzo; Arianna Mazzoli; Luisa Cigliano; Paola Venditti; Jean-Claude Walser; Alex Widmer; Loredana Baccigalupi; Ezio Ricca; Susanna Iossa
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

10.  Rapid small intestinal permeability assay based on riboflavin and lactulose detected by bis-boronic acid appended benzyl viologens.

Authors:  Angel Resendez; Md Abdul Halim; Caroline M Landhage; Per M Hellström; Bakthan Singaram; Dominic-Luc Webb
Journal:  Clin Chim Acta       Date:  2014-10-06       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.